Risk factors for lymphedema after breast cancer treatment. - Wikidata - awgldk - TriplyDB

Risk factors for lymphedema after breast cancer treatment.

Risk factors for lymphedema after breast cancer treatment.

http://www.wikidata.org/entity/Q34293178

about

Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy Conventional interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.Long-term risk of medical conditions associated with breast cancer treatment Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study.Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study Risk factors associated with breast cancer-related lymphedema in the WHEL Study Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer.Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance.Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction.Impact of lifestyle factors on prognosis among breast cancer survivors in the USA.Patient compliance with a health care provider referral for an occupational therapy lymphedema consult.The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review.Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.Usability and feasibility of health IT interventions to enhance Self-Care for Lymphedema Symptom Management in breast cancer survivors.Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer.Transient swelling versus lymphoedema in the first year following surgery for breast cancer.Development of breast cancer-related lymphedema: is it dependent on the patient, the tumor or the treating physicians?Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery.Quantitative Lymphoscintigraphy to Predict the Possibility of Lymphedema Development After Breast Cancer Surgery: Retrospective Clinical Study.The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema.CORR Insights®: Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma.Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.

P2860

Q24188134-BDF1E8D4-BA04-4E61-80A1-FE7AE70086C3 Q24200611-33CDF17B-2159-458D-8DDC-7AF2B9C46255 Q27001564-4CB92A65-BAD3-4E13-8339-6E7909CCE585 Q33571995-5772469E-E907-4678-99BF-99CE861FE724 Q33590486-9386E6C2-A84A-4621-858B-229AD00BEC84 Q33880910-3C3124FE-9FFA-4F39-8F52-E95363A3171B Q33895877-B26539D5-7F30-48C9-A1C5-0529024FB6A0 Q34304007-044ED0E8-512E-44F0-96E7-25C8E200F11D Q34585025-41EF10C1-B967-466B-8D12-AD38A781AC50 Q34683635-CF68BDB7-3F5F-4171-934B-453F1B431135 Q35490056-D7A5AB0B-6410-4CF5-93DA-D1358205CC0C Q35607357-3763CA66-03ED-44AA-93D6-11279A5050D2 Q35862349-F5730CFF-A6E0-480F-BD76-351EC795E09F Q35868204-89C412D4-9B73-4915-A03C-34F96BB54C10 Q36143741-DE1237D3-FA2F-4328-A8B5-092F2ACA2912 Q36597735-1D7D9819-172B-4444-A838-2D3E896600D2 Q36914435-FF403C45-B078-4FA7-A105-9735543A10A8 Q37210955-5A7DF359-4DFF-41D3-8F19-BFE3096BB641 Q37341815-1F809769-7BA0-4AF6-91F4-5108BF35CD86 Q37356012-C7222CF4-C91C-4586-9B96-C10673EF0148 Q37416098-F11EFB0C-C9FE-4B98-A061-19EA16571644 Q38023590-2A60BBD3-4D27-4C3D-AE18-42B079E21242 Q38042710-6266296E-D73C-4085-B805-B6B42AD039E5 Q38187579-9DCD2D3B-6278-4B2A-BE21-216047B835AF Q38263087-B2D2FE9A-E308-42E8-AA3D-88ACE5F43006 Q38616416-C4A8D02E-DEEF-441A-A7DE-1059088F0ACE Q38648224-570195C7-C26E-472C-8853-84D6E41896B0 Q38686027-A82A5BA9-4975-4367-97B9-E28C3695A6E8 Q38932021-D64BC492-3220-4EA7-ACBB-AF730CEC9D2C Q39568660-C5EB0945-1C21-4F36-87A9-2CF2B728618E Q40872781-17580AB0-3388-4F65-80C0-ACE6211E1D53 Q41104725-2A197BCA-A939-46F3-B031-603A2FAE7967 Q43964129-6937D1D7-3192-452E-962B-B1ECFFB451AA Q44149353-A55460F1-4FC0-40FB-B50E-175B725FB0F5 Q45179350-4FDFE5B8-ED8A-425D-AF90-9D6FD940E4B2 Q47662045-04A6CFB9-0BF6-4487-AB6B-07B757CF2CEC Q48200283-D8A70C16-32FE-4D04-897B-B144E20E4B0A Q50855417-2EE1DFDF-793E-4711-A195-B8B7F9398438 Q52837731-F22060CA-924B-468B-86CC-AD5A1EE9160F Q53258390-EC8FE802-E30B-41BF-BD47-E77142482D6A

P2860

Risk factors for lymphedema after breast cancer treatment.

http://www.wikidata.org/entity/Q34293178

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Risk factors for lymphedema after breast cancer treatment.

@ast

Risk factors for lymphedema after breast cancer treatment.

@en

Risk factors for lymphedema after breast cancer treatment.

@nl

type

label

Risk factors for lymphedema after breast cancer treatment.

@ast

Risk factors for lymphedema after breast cancer treatment.

@en

Risk factors for lymphedema after breast cancer treatment.

@nl

prefLabel

Risk factors for lymphedema after breast cancer treatment.

@ast

Risk factors for lymphedema after breast cancer treatment.

@en

Risk factors for lymphedema after breast cancer treatment.

@nl

P1433

Q34293178-339D8EB4-AB29-4703-9C6F-474D274C89FD

P1476

Q34293178-5E618A38-3639-4F52-AB90-C8725CDBEE90

P2093

Q34293178-016EB73E-6D69-4326-BDF2-5A64BE38185C

Q34293178-0D3B14A2-D642-4623-9446-F92086C8CFC3

Q34293178-0FE84480-5F4F-4F3D-B8F6-4EEECAC3AB04

Q34293178-1F286314-551C-4592-B4D4-E86C4AE314D3

Q34293178-41BAB0F5-5C5C-49D7-AA90-2E42A0A39170

Q34293178-6FECC700-1C81-483C-A04E-7F72DB1425D1

Q34293178-8C2F2A6E-13C0-4892-8950-5F68569CADB6

Q34293178-92DD4D91-1B5C-44BE-98C6-C6644620B5B9

Q34293178-CF216825-DA56-4FA8-9B71-DA4443281721

Q34293178-E69618D5-20C6-4D9E-B1D2-B97DE272D9F6

P2860

Q34293178-09E324AF-0330-4F36-98EC-424D5887126C

Q34293178-0BBFBA2A-74DA-4746-9F46-464314222E5B

Q34293178-10FFA353-77C9-4089-80BB-23C591C4325B

Q34293178-15839EBD-B55A-4D15-9B11-129E4FF6468C

Q34293178-291894CE-3A83-4D5F-BE43-58A2D1AE89A5

Q34293178-2A7084C0-CD19-4121-B4FC-7D01100D92F2

Q34293178-300E7A14-277F-4AD8-A857-E721E96204A8

Q34293178-383D2C14-126A-4A20-BA8F-DAA13A1BEDD5

Q34293178-39170E12-6F89-4AA0-BE4E-B989FA7ED9FC

Q34293178-395E31C1-CECD-4927-B375-047EBFBD8A66

P304

Q34293178-AC5F546E-EEA7-4C61-8EB8-026AC59E7C29

P31

Q34293178-9D435EE1-D12C-4940-924D-AA0E9A6CEE13

P356

Q34293178-317BDB36-48F2-426C-A775-6C264DD0C56E

P433

Q34293178-B19DEF56-B204-4397-8E22-6B8737A7D8E8

P478

Q34293178-BDD17852-59FD-45F5-9541-881FF0BF142F

P577

Q34293178-30F0F105-653D-4112-BD59-B1E292F24ADE

P698

Q34293178-E2CAA128-78E4-4F3E-A51D-79929A79B310

P932

Q34293178-DF2B49E1-7598-4BD6-A7E7-2444481B75BE

P356

1055-9965.EPI-09-1245

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Risk factors for lymphedema after breast cancer treatment.

@en

P2093

A Russell Localio

http://www.w3.org/2001/XMLSchema#string

Angela DeMichele

http://www.w3.org/2001/XMLSchema#string

Anita L Weber

http://www.w3.org/2001/XMLSchema#string

Heather A Simoes Torpey

http://www.w3.org/2001/XMLSchema#string

Kevin R Fox

http://www.w3.org/2001/XMLSchema#string

Lawrence J Solin

http://www.w3.org/2001/XMLSchema#string

Linda T Miller

http://www.w3.org/2001/XMLSchema#string

Michael J Kallan

http://www.w3.org/2001/XMLSchema#string

Sandra A Norman

http://www.w3.org/2001/XMLSchema#string

Sheryl L Potashnik

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data.

A review of measures of lymphedema.

Lymphedema in women treated for breast cancer.

Lymphoedema following surgery for breast cancer.

Risk factors of arm lymphedema in breast cancer patients.

Lymphedema: current issues in research and management.

Arm edema in breast cancer patients.

9. Arm lymphoedema following breast cancer treatment.

Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer.

P304

2734-2746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-09-1245

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20978176

http://www.w3.org/2001/XMLSchema#string

P932

2976830

http://www.w3.org/2001/XMLSchema#string